Suppr超能文献

山竹(莽吉柿)中氧杂蒽酮类化合物对细胞周期蛋白依赖性激酶4抑制作用的构效关系

Structure activity relationship of xanthones for inhibition of Cyclin Dependent Kinase 4 from mangosteen (Garcinia mangostana L.).

作者信息

Vemu Bhaskar, Nauman Mirielle C, Veenstra Jacob P, Johnson Jeremy J

机构信息

University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice.

出版信息

Int J Nutr. 2019;4(2):38-45. Epub 2019 Jun 16.

Abstract

The mangosteen fruit is a popular Southeast Asian fruit consumed for centuries. There have been a variety of xanthones isolated from the fruit, bark, roots and leaves with each having unique chemical and physical properties. Previously, the most abundant xanthone α-mangostin has been shown to inhibit CDK4. Herein we describe the role of selected xanthones from the mangosteen inhibiting CDK4. The evidence we provide here is that key functional groups are required to inhibit the CDK4 protein to prevent the phosphorylation of downstream targets critical to inhibiting uncontrolled cell cycle progression. To define the properties of xanthones for inhibiting CDK4 we utilized a cell free biochemical assay to identify inhibitors of CDK4. The following xanthones were used for the analysis: α-mangostin, β-mangostin, γ-mangostin, gartanin, 8-desoxygartanin, garcinone C and garcinone D, 9-hydroxycalabaxanthone, and 3-isomangostin These results further substantiate the unique pharmacological properties of individual xanthones and how a mixture of xanthones may be responsible for a multi-targeted effect in cell based pharmacology systems.

摘要

山竹果是一种深受欢迎的东南亚水果,几个世纪以来一直被食用。人们已从这种水果的果实、树皮、根和叶中分离出多种呫吨酮,每种呫吨酮都具有独特的化学和物理性质。此前已表明,含量最高的呫吨酮α-倒捻子素能够抑制细胞周期蛋白依赖性激酶4(CDK4)。在此,我们描述了山竹果中选定的呫吨酮对CDK4的抑制作用。我们在此提供的证据是,抑制CDK4蛋白以防止对抑制不受控制的细胞周期进程至关重要的下游靶点磷酸化需要关键官能团。为了确定呫吨酮抑制CDK4的特性,我们利用无细胞生化测定法来鉴定CDK4的抑制剂。分析使用了以下呫吨酮:α-倒捻子素、β-倒捻子素、γ-倒捻子素、藤黄菌素、8-脱氧藤黄菌素、藤黄酮C和藤黄酮D、9-羟基卡拉巴呫吨酮以及3-异倒捻子素。这些结果进一步证实了各个呫吨酮独特的药理特性,以及呫吨酮混合物如何在基于细胞的药理系统中产生多靶点效应。

相似文献

2
Inhibition of CDK2/CyclinE1 by xanthones from the mangosteen (): a structure-activity relationship study.
Nat Prod Res. 2021 Dec;35(23):5429-5433. doi: 10.1080/14786419.2020.1777413. Epub 2020 Jul 21.
3
The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones.
Pharmacol Res. 2022 Jan;175:106032. doi: 10.1016/j.phrs.2021.106032. Epub 2021 Dec 9.
4
Identification and Pharmacokinetics of Quinone Reductase 2 Inhibitors after Oral Administration of L. Extract in Rat by LC-MS/MS.
J Agric Food Chem. 2020 Oct 28;68(43):11975-11986. doi: 10.1021/acs.jafc.0c04439. Epub 2020 Oct 15.
5
HPLC analysis of selected xanthones in mangosteen fruit.
J Sep Sci. 2007 Jun;30(9):1229-34. doi: 10.1002/jssc.200700024.
6
Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen).
J Agric Food Chem. 2006 Mar 22;54(6):2077-82. doi: 10.1021/jf052649z.
8
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).
J Nat Prod. 2009 Nov;72(11):2028-31. doi: 10.1021/np900517h.

引用本文的文献

2
Exploring the antineoplastic potential of α-mangostin in breast cancer.
Nat Prod Bioprospect. 2025 Jul 3;15(1):43. doi: 10.1007/s13659-025-00528-5.
3
Naturally Occurring Xanthones and Their Biological Implications.
Molecules. 2024 Sep 6;29(17):4241. doi: 10.3390/molecules29174241.
5
A Mechanistic Review on Protective Effects of Mangosteen and its Xanthones Against Hazardous Materials and Toxins.
Curr Neuropharmacol. 2024;22(12):1986-2015. doi: 10.2174/1570159X22666240212142655.
9
The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones.
Pharmacol Res. 2022 Jan;175:106032. doi: 10.1016/j.phrs.2021.106032. Epub 2021 Dec 9.
10
Novel Xanthone Derivatives Impair Growth and Invasiveness of Colon Cancer Cells In Vitro.
Biomolecules. 2021 Oct 7;11(10):1480. doi: 10.3390/biom11101480.

本文引用的文献

1
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest.
Trends Cell Biol. 2018 Nov;28(11):911-925. doi: 10.1016/j.tcb.2018.07.002. Epub 2018 Jul 27.
2
Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update.
Food Chem Toxicol. 2017 Nov;109(Pt 1):102-122. doi: 10.1016/j.fct.2017.08.021. Epub 2017 Aug 24.
3
Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Pharmacol Ther. 2017 May;173:83-105. doi: 10.1016/j.pharmthera.2017.02.008. Epub 2017 Feb 5.
4
Cell cycle proteins as promising targets in cancer therapy.
Nat Rev Cancer. 2017 Jan 27;17(2):93-115. doi: 10.1038/nrc.2016.138.
6
Gartanin, an isoprenylated xanthone from the mangosteen fruit (Garcinia mangostana), is an androgen receptor degradation enhancer.
Mol Nutr Food Res. 2016 Jun;60(6):1458-69. doi: 10.1002/mnfr.201600037. Epub 2016 May 19.
8
Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data.
Clin Breast Cancer. 2016 Feb;16(1):8-17. doi: 10.1016/j.clbc.2015.07.005. Epub 2015 Jul 26.
9
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment.
Clin Cancer Res. 2015 Jul 1;21(13):2905-10. doi: 10.1158/1078-0432.CCR-14-0816. Epub 2015 May 4.
10
Inhibition of CHOP accentuates the apoptotic effect of α-mangostin from the mangosteen fruit (Garcinia mangostana) in 22Rv1 prostate cancer cells.
Biochem Biophys Res Commun. 2014 Oct 10;453(1):75-80. doi: 10.1016/j.bbrc.2014.09.054. Epub 2014 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验